Local accumulation of FOXP3+ regulatory T cells: Evidence for an immune evasion mechanism in patients with large condylomata acuminata

Journal of Immunology

Volumn 180, Issue 11, 2008, Pages 7681-7686

  Cao, Yuchun ^a   Zhao, Jie ^a   Lei, Zhang ^a   Shen, Shiqian ^a   Liu, Cong ^a   Li, Dong ^a   Liu, Jihong ^a   Shen, Guan Xin ^a   Zhang, Gui Mei ^a   Feng, Zuo Hua ^a   Huang, Bo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MACROPHAGE DERIVED CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; CCR4 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR4; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; GAMMA INTERFERON; INTERLEUKIN 2;

ARTICLE; CELL INFILTRATION; CHEMOTAXIS; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LANGERHANS CELL; MACROPHAGE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; VERRUCA VULGARIS; BIOSYNTHESIS; CELL MOTION; CYTOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM;

CELL MOVEMENT; CHEMOKINE CCL17; CHEMOKINE CCL22; CONDYLOMATA ACUMINATA; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; LANGERHANS CELLS; MACROPHAGES; RECEPTORS, CCR4; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 47249099764     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.11.7681     Document Type: Article

References (42)

1. Dupin, N. 2004. Genital warts. Clin. Dermatol. 22: 481-486.
2. Dunne, E. F., and L. E. Markowitz. 2006. Genital human papillomavinis infection. Clin. Infect. Dis. 43: 624-629.
3. Stanley, M. 2006. Immune responses to human papillomavirus. Vaccine 24 (Suppl. 1): S16-S22.
4. Hong, K., C. E. Greer, N. Ketter, G. Van Nest, and X. Paliard. 1997. Isolation and characterization of human papillomavirus type 6-specific T cells infiltrating genital warts. J. Virol. 71: 6427-6432.
5. Woodworth, C. D. 2002. HPV innate immunity. Front. Biosci. 7: 2058-2071.
6. Nees, M., J. M. Geoghegan, T. Hyman, S. Frank, L. Miller, and C. D. Woodworth. 2001. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-κB-responsive genes in cervical keratinocytes. J. Virol. 75: 4283-4296.
7. Barnard, P., and N. A. McMillan. 1999. The human papillomavirus E7 oncop-rotein abrogates signaling mediated by interferon-α. Virology 259: 305-313.
8. Ronco, L. V., A. Y. Karpova, M. Vidal, and P. M. Howley. 1998. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12: 2061-2072.
9. Chang, Y. E., and L. A. Laimins. 2000. Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. J. Virol. 74: 4174-4182.
10. Kupper, T. S., and R. C. Fuhlbrigge. 2004. Immune surveillance in the skin: mechanisms and clinical consequences. Nat. Rev. Immunol. 4: 211-222.
11. Le Bon, A., and D. F. Tough. 2002. Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 14: 432-436.
12. Theofilopoulos, A. N., R. Baccala, B. Beutler, and D. H. Kono. 2005. Type I inter-ferons (α/β) in immunity and autoimmunity. Annu. Rev. Immunol. 23: 307-336.
13. O'Garra, A., and P. Vieira. 2004. Regulatory T cells and mechanisms of immune system control. Nat. Med. 10: 801-805.
14. + T cells. Curr. Opin. Immunol. 15: 690-696.
15. Campbell, D. J., and S. F. Ziegler. 2007. FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat. Rev. Immunol. 7: 305-310.
16. Curiel, T. J., G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J. R. Conejo-Garcia, L. Zhang, M. Burow, et al. 2004. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10: 942-949.
17. Shevach, E. M. 2004. Fatal attraction: tumors beckon regulatory T cells. Nat. Med. 10: 900-901.
18. Beyer, M., and J. L. Schultze. 2006. Regulatory T cells in cancer. Blood 108: 804-811.
19. + regulatory T cells induced by chronic retroviral infection. Proc. Natl. Acad. Sci. USA 98: 9226-9230.
20. Toy, S. T., and E. F. Whellock. 1975. In vitro depression of cellular immunity by Friend virus leukemic spleen cells. Cell. Immunol. 17: 57-73.
21. Belkaid, Y., and B. T. Rouse. 2005. Natural regulatory T cells in infectious disease. Nat. Immunol. 6: 353-360.
22. Rouse, B. T., P. P. Sarangi, and S. Suvas. 2006. Regulatory T cells in virus infections. Immunol. Rev. 212: 272-286.
23. + subset. Cancer Res. 47: 3317-3321.
24. + regulatory T cells, which suppress induction of contact hypersensitivity. J. Dermatol. Sci. 39: 105-112.
25. + regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunol. Immunolher. 56: 641-648.
26. + regulatory T cells. J. Exp. Med. 194: 847-853.
27. + T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J. Exp. Med. 201: 1037-1044.
28. Imai, T., D. Chantry, C. J. Raport, C. L. Wood, M. Nishimura, R. Godiska, O. Yoshie, and P. W. Gray. 1998. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J. Biol. Chem. 273: 1764-1768.
29. + T cells and high concentration of its ligands (TARC and MDC) in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. Allergy 58: 518-523.
30. Roos, R. S., M. Loetscher, D. F. Legler, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1997. Identification of CCR8, the receptor for the human CC chemokine 1-309. J. Biol. Chem. 272: 17251-17254.
31. + regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104: 3249-3256.
32. + regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40: 1062-1071.
33. Amante, F. H., A. C. Stanley, L. M. Randall, Y. Zhou, A. Haque, K. McSweeney, A. P. Waters, C. J. Janse, M. F. Good, G. R. Hill, and C. R. Engwerda. 2007. A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria. Am. J. Pathol. 171: 548-559.
34. + T cell regulation of airway allergic responses depends on IL-10 induction of TGF-β. J. Immunol. 178: 1433-1442.
35. + regulatory T cells. J. Immunol. 177: 896-904.
36. Kim, H. J., S. J. Hwang, B. K. Kim, K. C. Jung, and D. H. Chung. 2006. NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor β, and by clonally deleting antigen-specific T cells. Immunology 118: 101-111.
37. + regulatory T cells is antigen-specific and requires IL-10 and TGF-β. J. Immunol. 175: 4283-4291.
38. Beutner, K. R., and A. Ferenczy. 1997. Therapeutic approaches to genital warts. Am. J. Med. 102: 28-37.
39. Ferenczy, A., M. Mitao, N. Nagai, S. J. Silverstein, and C. P. Crum. 1985. Latent papillomavirus and recurring genital warts. N. Engl. J. Med. 313: 784-788.
40. Onizuka, S., I. Tawara, J. Shimizu, S. Sakaguchi, T. Fujita, and E. Nakayama. 1999. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody. Cancer Res. 59: 3128-3133.
41. + immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66: 1123-1131.
42. + cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J. Exp. Med. 201: 779-791.